Viemed Healthcare, Inc. (NASDAQ:VMD – Get Free Report) Director Randy E. Dobbs sold 36,261 shares of the stock in a transaction that occurred on Wednesday, November 13th. The stock was sold at an average price of $9.28, for a total value of $336,502.08. Following the transaction, the director now directly owns 107,706 shares of the company’s stock, valued at approximately $999,511.68. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website.
Viemed Healthcare Stock Performance
VMD opened at $9.15 on Thursday. Viemed Healthcare, Inc. has a 1-year low of $6.21 and a 1-year high of $10.44. The stock has a market cap of $356.30 million, a P/E ratio of 33.89 and a beta of 1.43. The stock’s 50 day simple moving average is $8.31 and its 200 day simple moving average is $7.53. The company has a debt-to-equity ratio of 0.03, a current ratio of 1.31 and a quick ratio of 1.19.
Viemed Healthcare (NASDAQ:VMD – Get Free Report) last released its earnings results on Wednesday, November 6th. The company reported $0.10 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.08 by $0.02. Viemed Healthcare had a net margin of 4.87% and a return on equity of 8.72%. The company had revenue of $58.00 million for the quarter.
Hedge Funds Weigh In On Viemed Healthcare
Viemed Healthcare Company Profile
Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.
Featured Articles
- Five stocks we like better than Viemed Healthcare
- Stock Average Calculator
- Shopify Stock Rally Continues: Why the Growth Story Isn’t Over
- What Are Dividend Champions? How to Invest in the Champions
- Tariff Troubles: 3 Stocks Planning Higher Prices
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- Mercer Near Rock Bottom: Is This High-Yield Play Set to Soar?
Receive News & Ratings for Viemed Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Viemed Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.